AP
AtonRa Partners Portfolio holdings
AUM
$50.2M
This Quarter Return
+12.94%
1 Year Return
+47.76%
3 Year Return
+48.37%
5 Year Return
–
10 Year Return
–
AUM
$273M
AUM Growth
+$273M
(+22%)
Cap. Flow
+$32.1M
Cap. Flow
% of AUM
11.76%
Top 10 Holdings %
Top 10 Hldgs %
21.2%
Holding
121
New
13
Increased
46
Reduced
53
Closed
9
Top Buys
| 1 |
Marvell Technology
MRVL
|
$3.61M |
| 2 |
SolarEdge
SEDG
|
$3.4M |
| 3 |
Veeva Systems
VEEV
|
$3.31M |
| 4 |
Quanterix
QTRX
|
$2.99M |
| 5 |
SoFi Technologies
SOFI
|
$2.65M |
Top Sells
| 1 |
Vertex Pharmaceuticals
VRTX
|
$2.86M |
| 2 |
Guardant Health
GH
|
$2.75M |
| 3 |
Illumina
ILMN
|
$2.18M |
| 4 |
Moderna
MRNA
|
$2.16M |
| 5 |
Alnylam Pharmaceuticals
ALNY
|
$2.05M |
Sector Composition
| 1 | Technology | 44.69% |
| 2 | Healthcare | 32.32% |
| 3 | Financials | 8.45% |
| 4 | Industrials | 7.11% |
| 5 | Consumer Discretionary | 3.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Kymera Therapeutics
KYMR
$3.1B
| $1.31M | 0.48% |
+26,958
| New | +$1.31M |
|
77
Acadia Pharmaceuticals
ACAD
$4.34B
| $1.31M | 0.48% |
53,527
+5,373
| +11% | +$131K |
|
78
NVIDIA
NVDA
$4.15T
| $1.29M | 0.47% |
6,453
-146
| -2% | -$29.2K |
|
79
Booz Allen Hamilton
BAH
$13.2B
| $1.28M | 0.47% |
15,007
-2,222
| -13% | -$189K |
|
80
Rapid7
RPD
$1.32B
| $1.23M | 0.45% |
12,973
-730
| -5% | -$69.1K |
|
81
Exact Sciences
EXAS
$9.33B
| $1.21M | 0.45% |
9,769
+109
| +1% | +$13.5K |
|
82
Varonis Systems
VRNS
$6.21B
| $1.2M | 0.44% |
20,881
-907
| -4% | -$52.3K |
|
83
Fidelity National Information Services
FIS
$35.6B
| $1.18M | 0.43% |
8,302
-342
| -4% | -$48.4K |
|
|
SGEN
84
DELISTED
Seagen Inc. Common Stock
SGEN
| $1.15M | 0.42% |
7,270
+812
| +13% | +$128K |
|
85
Teledyne Technologies
TDY
$25.5B
| $1.11M | 0.41% |
2,655
-266
| -9% | -$111K |
|
|
XLRN
86
DELISTED
Acceleron Pharma Inc.
XLRN
| $1.1M | 0.4% |
+8,798
| New | +$1.1M |
|
87
Coherent
COHR
$13.8B
| $1.09M | 0.4% |
15,049
-360
| -2% | -$26.1K |
|
88
Butterfly Network
BFLY
$378M
| $1.08M | 0.4% |
74,796
-4,720
| -6% | -$68.3K |
|
89
Adaptive Biotechnologies
ADPT
$1.96B
| $1.07M | 0.39% |
+26,249
| New | +$1.07M |
|
90
Neurocrine Biosciences
NBIX
$13.5B
| $1.06M | 0.39% |
10,903
-17,510
| -62% | -$1.7M |
|
91
Zebra Technologies
ZBRA
$15.5B
| $1.05M | 0.38% |
1,973
-77
| -4% | -$40.8K |
|
|
BNR
92
Burning Rock Biotech
BNR
$85.6M
| $1.04M | 0.38% |
35,443
-207
| -0.6% | -$6.1K |
|
|
MANT
93
DELISTED
Mantech International Corp
MANT
| $1.04M | 0.38% |
12,051
-1,662
| -12% | -$144K |
|
|
BPMC
94
DELISTED
Blueprint Medicines
BPMC
| $1M | 0.37% |
11,397
+2,674
| +31% | +$235K |
|
95
ServiceNow
NOW
$191B
| $1M | 0.37% |
1,821
-47
| -3% | -$25.8K |
|
96
Iridium Communications
IRDM
$2.62B
| $971K | 0.36% |
24,279
-2,144
| -8% | -$85.7K |
|
97
Ultragenyx Pharmaceutical
RARE
$3.04B
| $969K | 0.36% |
10,165
-10,852
| -52% | -$1.03M |
|
98
BlackLine
BL
$3.26B
| $955K | 0.35% |
8,579
+889
| +12% | +$99K |
|
99
Affirm
AFRM
$27.8B
| $930K | 0.34% |
13,814
-6,274
| -31% | -$422K |
|
100
Momentus
MNTS
$14.8M
| $928K | 0.34% |
66,403
-5,385
| -8% | -$75.3K |
|